Los Angeles Capital Management LLC Boosts Stock Holdings in Solventum Co. (NYSE:SOLV)

Los Angeles Capital Management LLC boosted its stake in Solventum Co. (NYSE:SOLV) by 670.0% during the 3rd quarter, Holdings Channel reports. The firm owned 40,888 shares of the company’s stock after buying an additional 35,578 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Solventum were worth $2,851,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in SOLV. Price T Rowe Associates Inc. MD purchased a new stake in shares of Solventum in the first quarter worth about $5,889,000. Mitsubishi UFJ Trust & Banking Corp bought a new position in shares of Solventum during the 1st quarter valued at approximately $5,747,000. CWM LLC purchased a new position in shares of Solventum in the second quarter valued at $473,000. Great Valley Advisor Group Inc. bought a new stake in Solventum in the second quarter worth $493,000. Finally, First Horizon Advisors Inc. purchased a new stake in Solventum during the second quarter valued at $58,000.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on SOLV shares. Morgan Stanley lifted their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday. The Goldman Sachs Group lifted their price target on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research report on Monday, August 12th. Wells Fargo & Company decreased their price objective on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Friday, August 9th. Stifel Nicolaus assumed coverage on Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Finally, Wolfe Research began coverage on Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. One research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $68.00.

Solventum Trading Down 1.2 %

SOLV opened at $70.70 on Wednesday. The business has a fifty day moving average of $70.23 and a 200 day moving average of $62.07. The company has a debt-to-equity ratio of 2.90, a quick ratio of 0.96 and a current ratio of 1.31. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.